| 1700 – 1705 |
Gastric Microbiome in Functional Dyspepsia |
Yasuhiro KOGA, Japan |
| 1705 - 1710 |
Oral Nutrition, Microbiome, and Intestinal Barrier Function. |
Robert JENQ, University of Texas, USA |
| 1710 - 1715 |
Protective Effects of Probiotics against Heavy Metal Toxicity, A Human Trial |
Wei CHEN, Jiangnan University, China |
| 1715 - 1720 |
The Role of Probiotics in Human Reproduction |
Esther JIMÉNEZ, ProbiSearch, Spain |
| 1720 - 1725 |
Probiotics for Obesity |
Corinne GRANGETTE, Pasteur Institute of Lille, France. |
| 1725 - 1730 |
Potential of Bifidobacterium Breve A1 in the Prevention of Cognitive Impairment in Alzheimer's Disease |
Jin-zhong XIAO, Morinaga, Japan |
| 1730 - 1735 |
Evaluating Presence and Interaction of SCFAs in the Lungs |
Marianne KOLIANA, Imperial College, UK |
| 1735 - 1740 |
A Prebiotic Intervention Study in Children with Autism Spectrum Disorders |
Roberta GRIMALDI, Clasado, The Channel Islands |
| 1740 - 1745 |
Prebiotic Effect of Biosynthetic Inulin |
Keiji WAKABAYASHI, University of Shizouka, Japan |
| 1745 - 1750 |
Probiotic Issues from Argentina |
Gabriel VINDEROLA, CONICET, Argentina |
| 1750 - 1755 |
The influence of 2’-fucosyllactose on simulated colon microbiota and B. infantis Bi-26 metabolism |
Arthur OUWEHAND, DuPont, Finland |
| 1755 - 1800 |
NIZO’s Probiotic Optimization Pipeline for the Production and Down-stream Processing of Gut-derived Strict Anaerobes |
Martijn BEKKER, NIZO, Netherlands |
